Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut Microbiota
COVID-19 is mainly associated with respiratory distress syndrome, but a subset of patients often present gastrointestinal (GI) symptoms. Imbalances of gut microbiota have been previously linked to respiratory virus infection. Understanding how the gut–lung axis affects the progression of COVID-19 ca...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2021.712081/full |
id |
doaj-6b6b434d16f8458b9e4ffc6d5411d5bc |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sijia Li Siyuan Yang Yuzheng Zhou Cyrollah Disoma Zijun Dong Ashuai Du Yongxing Zhang Yong Chen Weiliang Huang Junru Chen Deqiang Song Zongpeng Chen Pinjia Liu Shiqin Li Rong Zheng Sixu Liu Aroona Razzaq Xuan Chen Siyi Tao Chengping Yu Tianxu Feng Wenyan Liao Yousong Peng Taijiao Jiang Jufang Huang Wei Wu Liqiang Hu Linghang Wang Shanni Li Zanxian Xia |
spellingShingle |
Sijia Li Siyuan Yang Yuzheng Zhou Cyrollah Disoma Zijun Dong Ashuai Du Yongxing Zhang Yong Chen Weiliang Huang Junru Chen Deqiang Song Zongpeng Chen Pinjia Liu Shiqin Li Rong Zheng Sixu Liu Aroona Razzaq Xuan Chen Siyi Tao Chengping Yu Tianxu Feng Wenyan Liao Yousong Peng Taijiao Jiang Jufang Huang Wei Wu Liqiang Hu Linghang Wang Shanni Li Zanxian Xia Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut Microbiota Frontiers in Microbiology COVID-19 SARS-CoV-2 gut microbiota gastrointestinal symptoms microbiome |
author_facet |
Sijia Li Siyuan Yang Yuzheng Zhou Cyrollah Disoma Zijun Dong Ashuai Du Yongxing Zhang Yong Chen Weiliang Huang Junru Chen Deqiang Song Zongpeng Chen Pinjia Liu Shiqin Li Rong Zheng Sixu Liu Aroona Razzaq Xuan Chen Siyi Tao Chengping Yu Tianxu Feng Wenyan Liao Yousong Peng Taijiao Jiang Jufang Huang Wei Wu Liqiang Hu Linghang Wang Shanni Li Zanxian Xia |
author_sort |
Sijia Li |
title |
Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut Microbiota |
title_short |
Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut Microbiota |
title_full |
Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut Microbiota |
title_fullStr |
Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut Microbiota |
title_full_unstemmed |
Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut Microbiota |
title_sort |
microbiome profiling using shotgun metagenomic sequencing identified unique microorganisms in covid-19 patients with altered gut microbiota |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Microbiology |
issn |
1664-302X |
publishDate |
2021-10-01 |
description |
COVID-19 is mainly associated with respiratory distress syndrome, but a subset of patients often present gastrointestinal (GI) symptoms. Imbalances of gut microbiota have been previously linked to respiratory virus infection. Understanding how the gut–lung axis affects the progression of COVID-19 can provide a novel framework for therapies and management. In this study, we examined the gut microbiota of patients with COVID-19 (n = 47) and compared it to healthy controls (n = 19). Using shotgun metagenomic sequencing, we have identified four microorganisms unique in COVID-19 patients, namely Streptococcus thermophilus, Bacteroides oleiciplenus, Fusobacterium ulcerans, and Prevotella bivia. The abundances of Bacteroides stercoris, B. vulgatus, B. massiliensis, Bifidobacterium longum, Streptococcus thermophilus, Lachnospiraceae bacterium 5163FAA, Prevotella bivia, Erysipelotrichaceae bacterium 6145, and Erysipelotrichaceae bacterium 2244A were enriched in COVID-19 patients, whereas the abundances of Clostridium nexile, Streptococcus salivarius, Coprococcus catus, Eubacterium hallii, Enterobacter aerogenes, and Adlercreutzia equolifaciens were decreased (p < 0.05). The relative abundance of butyrate-producing Roseburia inulinivorans is evidently depleted in COVID-19 patients, while the relative abundances of Paraprevotella sp. and the probiotic Streptococcus thermophilus were increased. We further identified 30 KEGG orthology (KO) modules overrepresented, with 7 increasing and 23 decreasing modules. Notably, 15 optimal microbial markers were identified using the random forest model to have strong diagnostic potential in distinguishing COVID-19. Based on Spearman’s correlation, eight species were associated with eight clinical indices. Moreover, the increased abundance of Bacteroidetes and decreased abundance of Firmicutes were also found across clinical types of COVID-19. Our findings suggest that the alterations of gut microbiota in patients with COVID-19 may influence disease severity. Our COVID-19 classifier, which was cross-regionally verified, provides a proof of concept that a set of microbial species markers can distinguish the presence of COVID-19. |
topic |
COVID-19 SARS-CoV-2 gut microbiota gastrointestinal symptoms microbiome |
url |
https://www.frontiersin.org/articles/10.3389/fmicb.2021.712081/full |
work_keys_str_mv |
AT sijiali microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT siyuanyang microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT yuzhengzhou microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT cyrollahdisoma microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT zijundong microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT ashuaidu microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT yongxingzhang microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT yongchen microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT weilianghuang microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT junruchen microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT deqiangsong microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT zongpengchen microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT pinjialiu microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT shiqinli microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT rongzheng microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT sixuliu microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT aroonarazzaq microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT xuanchen microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT siyitao microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT chengpingyu microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT tianxufeng microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT wenyanliao microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT yousongpeng microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT taijiaojiang microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT jufanghuang microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT weiwu microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT liqianghu microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT linghangwang microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT shannili microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota AT zanxianxia microbiomeprofilingusingshotgunmetagenomicsequencingidentifieduniquemicroorganismsincovid19patientswithalteredgutmicrobiota |
_version_ |
1716828339174375424 |
spelling |
doaj-6b6b434d16f8458b9e4ffc6d5411d5bc2021-10-11T07:32:46ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2021-10-011210.3389/fmicb.2021.712081712081Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut MicrobiotaSijia Li0Siyuan Yang1Yuzheng Zhou2Cyrollah Disoma3Zijun Dong4Ashuai Du5Yongxing Zhang6Yong Chen7Weiliang Huang8Junru Chen9Deqiang Song10Zongpeng Chen11Pinjia Liu12Shiqin Li13Rong Zheng14Sixu Liu15Aroona Razzaq16Xuan Chen17Siyi Tao18Chengping Yu19Tianxu Feng20Wenyan Liao21Yousong Peng22Taijiao Jiang23Jufang Huang24Wei Wu25Liqiang Hu26Linghang Wang27Shanni Li28Zanxian Xia29Hunan Key Laboratory of Animal Models for Human Diseases, Department of Cell Biology, School of Life Sciences, Central South University, Changsha, ChinaBeijing Key Laboratory of Emerging Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, ChinaHunan Key Laboratory of Animal Models for Human Diseases, Department of Cell Biology, School of Life Sciences, Central South University, Changsha, ChinaHunan Key Laboratory of Animal Models for Human Diseases, Department of Cell Biology, School of Life Sciences, Central South University, Changsha, ChinaHunan Key Laboratory of Animal Models for Human Diseases, Department of Cell Biology, School of Life Sciences, Central South University, Changsha, ChinaHunan Key Laboratory of Animal Models for Human Diseases, Department of Cell Biology, School of Life Sciences, Central South University, Changsha, ChinaHunan Key Laboratory of Animal Models for Human Diseases, Department of Cell Biology, School of Life Sciences, Central South University, Changsha, ChinaThe First Hospital of Changsha, Changsha, ChinaThe First Hospital of Changsha, Changsha, ChinaSuzhou Geneworks Technology Co., Ltd., Suzhou, ChinaSuzhou Geneworks Technology Co., Ltd., Suzhou, ChinaHunan Key Laboratory of Animal Models for Human Diseases, Department of Cell Biology, School of Life Sciences, Central South University, Changsha, ChinaHunan Key Laboratory of Animal Models for Human Diseases, Department of Cell Biology, School of Life Sciences, Central South University, Changsha, ChinaHunan Key Laboratory of Animal Models for Human Diseases, Department of Cell Biology, School of Life Sciences, Central South University, Changsha, ChinaHunan Key Laboratory of Animal Models for Human Diseases, Department of Cell Biology, School of Life Sciences, Central South University, Changsha, ChinaHunan Key Laboratory of Animal Models for Human Diseases, Department of Cell Biology, School of Life Sciences, Central South University, Changsha, ChinaHunan Key Laboratory of Animal Models for Human Diseases, Department of Cell Biology, School of Life Sciences, Central South University, Changsha, ChinaHunan Key Laboratory of Animal Models for Human Diseases, Department of Cell Biology, School of Life Sciences, Central South University, Changsha, ChinaHunan Key Laboratory of Animal Models for Human Diseases, Department of Cell Biology, School of Life Sciences, Central South University, Changsha, ChinaHunan Key Laboratory of Animal Models for Human Diseases, Department of Cell Biology, School of Life Sciences, Central South University, Changsha, ChinaXiangya School of Medicine, Central South University, Changsha, ChinaDepartment of Gynaecology and Obstetrics, The First Affiliated Hospital of University of South China, Hengyang, ChinaHunan Provincial Key Laboratory of Medical Virology, Bioinformatics Center, College of Biology, Hunan University, Changsha, ChinaCenter for Systems Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaHunan Key Laboratory of Animal Models for Human Diseases, Department of Cell Biology, School of Life Sciences, Central South University, Changsha, ChinaDepartment of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaThe First Hospital of Changsha, Changsha, ChinaBeijing Key Laboratory of Emerging Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, ChinaHunan Key Laboratory of Animal Models for Human Diseases, Department of Cell Biology, School of Life Sciences, Central South University, Changsha, ChinaHunan Key Laboratory of Animal Models for Human Diseases, Department of Cell Biology, School of Life Sciences, Central South University, Changsha, ChinaCOVID-19 is mainly associated with respiratory distress syndrome, but a subset of patients often present gastrointestinal (GI) symptoms. Imbalances of gut microbiota have been previously linked to respiratory virus infection. Understanding how the gut–lung axis affects the progression of COVID-19 can provide a novel framework for therapies and management. In this study, we examined the gut microbiota of patients with COVID-19 (n = 47) and compared it to healthy controls (n = 19). Using shotgun metagenomic sequencing, we have identified four microorganisms unique in COVID-19 patients, namely Streptococcus thermophilus, Bacteroides oleiciplenus, Fusobacterium ulcerans, and Prevotella bivia. The abundances of Bacteroides stercoris, B. vulgatus, B. massiliensis, Bifidobacterium longum, Streptococcus thermophilus, Lachnospiraceae bacterium 5163FAA, Prevotella bivia, Erysipelotrichaceae bacterium 6145, and Erysipelotrichaceae bacterium 2244A were enriched in COVID-19 patients, whereas the abundances of Clostridium nexile, Streptococcus salivarius, Coprococcus catus, Eubacterium hallii, Enterobacter aerogenes, and Adlercreutzia equolifaciens were decreased (p < 0.05). The relative abundance of butyrate-producing Roseburia inulinivorans is evidently depleted in COVID-19 patients, while the relative abundances of Paraprevotella sp. and the probiotic Streptococcus thermophilus were increased. We further identified 30 KEGG orthology (KO) modules overrepresented, with 7 increasing and 23 decreasing modules. Notably, 15 optimal microbial markers were identified using the random forest model to have strong diagnostic potential in distinguishing COVID-19. Based on Spearman’s correlation, eight species were associated with eight clinical indices. Moreover, the increased abundance of Bacteroidetes and decreased abundance of Firmicutes were also found across clinical types of COVID-19. Our findings suggest that the alterations of gut microbiota in patients with COVID-19 may influence disease severity. Our COVID-19 classifier, which was cross-regionally verified, provides a proof of concept that a set of microbial species markers can distinguish the presence of COVID-19.https://www.frontiersin.org/articles/10.3389/fmicb.2021.712081/fullCOVID-19SARS-CoV-2gut microbiotagastrointestinal symptomsmicrobiome |